Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era

Author: Nae-Yun NAE-YUN ¹
Author Information

1. Division of Gastroenterology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
Publication Type:RESEARCH UPDATE
From:The Korean Journal of Gastroenterology 2021;77(3):145-147
CountryRepublic of Korea
Language:English